Drug Profile
Erythropoietin gene therapy - Fresh Tracks Therapeutics
Alternative Names: EPO plasmid DNA - Fresh Tracks Therapeutics; Erythropoietin plasmid DNA - Fresh Tracks TherapeuticsLatest Information Update: 25 Sep 2023
Price :
$50
*
At a glance
- Originator Vical
- Developer Fresh Tracks Therapeutics
- Class Antianaemics; Gene therapies; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anaemia